Work

Cost-Utility Analysis of Recommended Ranibizumab Regimen for Age-Related Macular Degeneration in China

Year: 2014

Type: article

Source: Value in Health

DOI: 10.1016/j.jval.2014.08.2129

Authors: X. Ying, S. Feng, W. Wu, J. Chang

Institutions: Fudan University, Novartis (China)

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2316467942

FWCI: 0.828

Cites:

Cited by: 1

Related to: 10